Coppell Advisory Solutions’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Coppell Advisory Solutions's AMGN Position: Q2 2026 in Review
Coppell Advisory Solutions sold out of Amgen (AMGN) in Q2 2026, closing a stake of 4,099 shares — an estimated $1.43M sold.
Coppell Advisory Solutions first reported a position in AMGN in Q4 2020 and held it in 14 quarters. The position peaked at $4.33M in Q1 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Coppell Advisory Solutions reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Coppell Advisory Solutions sold 4,099 Amgen shares in Q2 2026, an estimated $1.43M.
- Coppell Advisory Solutions first reported a position in Amgen in Q4 2020 and held it in 14 quarters.
- Coppell Advisory Solutions's Amgen position peaked at $4.33M in Q1 2025.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.